Heterocyclic derivatives as platelet aggregation inhibitors

RS 3-Methyl-4-Ä4-(4-pyridyl)piperazin-1-ylÜphenoxybutyric acid and metabolically labile ester or amides thereof, and pharmaceutically acceptable salts thereof useful as an inhibitor of the binding of fibrinogen to glycoprotein IIb/IIIa.

Saved in:
Bibliographic Details
Main Authors MICHAEL JAMES SMITHERS, ANDREW GEORGE BREWSTER, PETER WILLIAM RODNEY CAULKETT, JOHN WALL RAYNER, ROBERT JAMES PEARCE, ALAN WELLINGTON FAULL, RICHARD EDEN SHUTE, MICHAEL GARTH WAYNE, STUART DENNETT MILLS
Format Patent
LanguageEnglish
Published 11.06.1998
Edition6
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:RS 3-Methyl-4-Ä4-(4-pyridyl)piperazin-1-ylÜphenoxybutyric acid and metabolically labile ester or amides thereof, and pharmaceutically acceptable salts thereof useful as an inhibitor of the binding of fibrinogen to glycoprotein IIb/IIIa.
Bibliography:Application Number: AU19940062889